Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

51 results about "Ciclopentolato" patented technology

Preparation method of (3R,5R)-3,5-dihydroxy-6-methyl cyan-caproate

The invention relates to a preparation method of (3R, 5R)-3,5-dihydroxy-6-methyl cyan-caproate (I) and belongs to the technical field of pharmaceutical chemistry. The preparation method concretely comprises the following steps of: firstly, carrying out asymmetric catalysis alcoholysis on 3-siloxy cyclopentane anhydride (II) to prepare (R)-3-siloxy-5-alkoxy-5-oxo-pentanoate (III); secondly, condensing the (R)-3-siloxy-5-alkoxy-5-oxo-pentanoate (III) and methyl cyanoacetate to prepare (R)-2-cyano-3-oxo-5-siloxy diethyl pimelate (IV); thirdly, carrying out decarboxylation on the (R)-2-cyano-3-oxo-5-siloxy diethyl pimelate (IV) to prepare (R)-3-hydroxy-5-oxo-6-benzyl cyanohexanoate (V) by using desilicication protective groups; and fourthly, carrying out asymmetric reduction on the (R)-3-hydroxy-5-oxo-6-benzyl cyanohexanoate to prepare a product of (3R,5R)-3,5-dihydroxy-6-methyl cyan-caproate (I). The preparation method is mild in reaction conditions, simple and convenient to operate, high in stereoselectivity, environment-friendly, and suitable for industrial production; and products have high yield, the used chiral catalyst is small in dosage and can be recovered with fix quantify, raw materials which are easily obtained are low in cost, and particularly hypertoxic cyanides are avoided.
Owner:FUDAN UNIV

Compound reserpine orally disintegrating tablet for treating hypertension and preparation method of compound reserpine orally disintegrating tablet

The invention belongs to the field of pharmacy, and particularly relates to a compound reserpine orally disintegrating tablet for treating hypertension and a preparation method of the compound reserpine orally disintegrating tablet. The compound reserpine orally disintegrating tablet is prepared from the following raw and auxiliary materials in parts by weight: 0.03 part of reserpine, 1 part of hydralazine hydrochloride, 0.025 part of cyclopenthiazide, 1.5 parts of hydrochlorothiazide, 2 parts of promethazine hydrochloride, 30 parts of potassium chloride, 5 parts of rutin, 2.5 parts of phosphate chloroquine, 1 part of vitamin B1, 1 part of vitamin B6, 2-10 parts of a stabilizer fumaric acid and other pharmaceutical adjuvants. An experiment result shows that the orally disintegrating tablet is short in onset time, long in medicine duration time, and convenient for treatment of a patient for a long period of time; the medication safety is improved; meanwhile, the prescription is high in process stability, and is free of effects of environmental temperature and humidity; and the difference between batches of the preparations is significantly reduced; and the stability of a sample is improved.
Owner:ZHENGZHOU TAIFENG PHARMA CO LTD

Environment-friendly tracer controlled release capsule and method thereof

The invention belongs to the field of oilfield tracing, and particularly relates to an environment-friendly tracer controlled release capsule and a method thereof. Aiming at the problems of poor slowrelease and stability of an existing oilfield tracer, the invention provides the following scheme that the controlled release capsule is prepared from the following raw materials in parts by weight: 10 to 15 percent of a biological coloring agent, 10 to 15 percent of an acid-base regulator, 5 to 10 percent of methyl fluorobenzoate, 1 to 5 percent of potassium hydrogen sulfate, 2 to 7 percent of cyclobutylsiloxane, 1 to 5 percent of cyclopentasiloxane, 1 to 5 percent of polyvinyl alcohol, 1 to 5 percent of chitosan, 2 to 6 percent of sodium carboxymethylcellulose, 3 to 7 percent of polyethyleneglycol and 4 to 9 percent of di-iso-decylphthalate. The tracer controlled release capsule provided by the invention is injected into a target stratum along with fluid; when the tracer controlled release capsule is in contact with target fluid, a tracer component starts to be slowly released; and the tracer component is carried out by the target fluid; the concentration of the tracer component issampled and analyzed at a wellhead, so that the aim of monitoring the target fluid is fulfilled.
Owner:权冉(银川)科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products